chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented today, 03/17/2022 for Pfizer booster. During registration revealed he received  05/10/2021 and 05/21/2021. Patient did not reveal this info when he received Pfizer with us on 09/25/2021 or 10/16/2021 as documented in this report.  Patient was educated he is fully vaccinated and did not receive any additional CV19 vaccinations today.
A vaccine dose from an expired shelf life of a pfizer vial was administered to the patient. Approximate time passed was 20-21 hrs after. A cascades of events lead to this . I had thought the vial had been mixed by staff pharmacist earlier in the day.  However, vial was left from night prior.  Unsure if the time period passed for the shelf life would still give the immunity patient needs or if it would be harmful to the patient. patient has been informed and pending manufacturer's recommendation to repeat the dose or not. no symptoms has been reported from the patient yet.
itching on palms and feet - sometimes severe.  No rash or redness, just itching.
pt recv vax 6NOV96 & 2hr p/vax pt exp lt sided facial paralysis described as Bell's Palsy;
Patient presented to the ED complaining of worsening dyspnea, chest pain, and right lower extremity swelling. He was found to have bilateral extensive PE with signs of right heart strain on CTA in the ED. Additionally found to have DVT of right external iliac vein, right common femoral vein, right proximal femoral vein, and occlusive DVT of right deep femoral vein. ECHO showed RV systolic function was severely reduced. He received a heparin bolus and drip in the emergency department, Vascular Surgery was consulted for suction thrombectomy completed on 12/9 for his PE. Additional thrombectomy 12/10 scheduled for RLE. He was successfully weaned off O2 post thrombectomy, plans for likely discharge home 12/11 pending clinical course.
Case number PHEH2014US024970, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 70 year old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 30 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date). On 03-Jan-2022, EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The dose administered after 30-day used by date. The vial was initially stored in the refrigerator 01-Dec-2021. No concomitant products were reported. No treatment information was reported.
Chills: Cold, shivering, 12 hour duration Headache: Pain in my head, 24 hours duration Fatigue: Excessive tiredness, 36 hours duration Pain at injection site: immediate, 48 hour duration
pt to hosp with dyspnea that's been increasing over last 5 days; associated with cough, fever, diarrhea; DNR: O2 supplementation; required intubation with mechanical ventilation; decrease in renal function, hyperkalemia, anuria; wife wanted pt to be transitioned to comfort measures, and pt passed away in the hospital
Patient states she experienced swollen, red, and itching at site of injection. She was seen by PCP and Dr. wrote an Rx for an antibiotic for her.
She mentioned chest pains and stiffness of the hand immediately. They advised her to keep moving her hand. When she mentioned the chest pains, we went straight to the hospital. This was on Saturday. They did an ekg which was normal. When we came home she said that her stomach was hurting. I kept giving her water but the following morning, she continued to complain of pain in her stomach and under her arm pit on the same side she received her vaccine. I put Neosporin on it because I was advised by a doctor before to use it for this type of pain. I called the nurse line and they said it could be a swollen lymph node. They advised me not to treat it but to wait until the pediatrician examined her. She then told me the chest pain was back. She went to the bathroom and she had a runny stomach. We went to the ER yesterday around 10pm for chest pain and they did an ekg, x-ray, and bloodwork. They said everything looks good and to come back if the chest pains worsen, I am going to set up an appointment with the pediatrician. We are also going to see a cardiologist. The ER indicated that they think this is anxiety related as they had done all preliminary testing and did not see anything. They ruled out myocardial issues. She started having breathing issues when walking into the hospital. Today she is indicating that she is still having the chest pains. At least 3 times today. We have an appointment with a Pediatric cardiologist on Thursday. She still has the pain in her under arm.
pt recvd vax & 48 hrs p/vax exp sore lips, sore face, sores on tongue & tasted shot; tongue very red, swollen & had deep crevices in it; c/o flushed required to see family MD; sore (blisters-like);
15 year old received first and second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first and second dose) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first and second dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first and second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.    No treatment information was provided.  Patient had no problem with both doses   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received on 27-JUL-2021 it contained second dose information, patient demographics were added. On 04-Sep-2021: Non significant follow up-patient initials added
15FEB93 fever 103 R, muscle twitching & irregular breathing; fever of 103-104 cont through 17FEB93; fine on 18FEB93; 19FEB93 rash on torso; seen on 17FEB93 by MD ear infection; Augmentin & pediaprofin for fever prescribed; recovered;
Very Severe swelling of both gums and lips. Unable to open mouth wide enough to eat for several days.  Straw diet.  Benadryl orally helped over time.  EpiPen on hand for any possible immediate or delayed anaphylactic reaction.
small rash on left wrist and around lips and mouth/ extremely itchy; small rash on left wrist and around lips and mouth/ extremely itchy; small rash on left wrist and around lips and mouth/ extremely itchy; small rash on left wrist and around lips and mouth/ extremely itchy; small rash on left wrist and around lips and mouth/ extremely itchy; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route on left arm on 21Dec2020 12:30 PM, single dose for COVID-19 immunization at 36-year-old. Medical history included: allergies: penicillins. Prior to vaccination, the patient did not diagnose with COVID-19. Concomitant medications in two weeks of vaccination included: fluoxetine 20mg from Dec2020. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Dec2020 05:00 AM, after the injection, the patient developed a small rash on her left wrist and around her lips and mouth. It was extremely itchy and remained after three days. No treatment received. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the event was not resolved. It was reported as non-serious.  Information on the lot/batch number has been requested.
Daily headache for 5.5 months.  Relieved with OTC medication most of the time.
Presented with increased sleeping, decreased oral intake.  On exam: lethargic, with irritability on awakening.  Admitted to hospital.
Pt received multiple vaccines in preparation for deployment. He reports being in good health prior to August 2003 and has stated that he has never had an adverse reaction to any immunizations. On Aug02,2003 he recalls having a severe occipital headache with pains into his neck followed 3 hours later with the onset of a 20-30 min episode of tunnel vision. He denies any fever, chills, nausea, vomiting, dizziness, numbness or weakness. He was seen at the TMC where he felt groggy and confused and says he had loss consciousness for 2-3 hours. He was treated with IV fluids, pain medication and given quarters. All labs were normal. He reports feeling exhausted and sleeping for 16hrs-they woke me to eat and I went right back to sleep. The next day he recalls feeling foggy, with decreased comprehension and concentration- I was unable to complete sentences. The headache slowly improved to (2-3/10) and he was deployed on ASA and or Motrin where he continued to have mild headaches, dull, achy pain 3-4 x a week. He received an influenza vaccine on 14Oct03, and says his headaches became worse occurring daily and lasting 4-12 hrs. with only minimal relief with ASA or Motrin. He also started having tinnitus described as a high pitch, constant background sound bilaterally. In November he began experiencing daily episodes of sharp dagger like pains (8-9/10) localized in his right temporal area lasting 2-3 seconds at times, associated with nausea. He also states that he had 1 episode of photo phobia and dulled mental status associated with these headaches in December. About the middle of December he began having painless fluttering of his right eyelid and right sided facial twitching. A CT scan showed mild sinusitis and possible vascular malformation in the left occipital lobe. He was transferred. He had a normal MRI/MRA/MRV EEG and routine labs. He was treated with a prednisone taper and Neurontin 300mg HS with some improvement in the sharp, intermittent headache pains. While being air evacuated he had 2 episodes of uncontrollable stiffening of my entire body (extension of his arms and legs, stiffening of his tongue)- the first lasting 5 minutes and the second 20 minutes-associated with tachycardia. He denies loss of bowel or bladder control, LOC, nausea, vomiting, headache or blurred vision.
Dizziness; Ringing in the ears; Headache; Nausea; Slight fever (100.3); Wheezing; Excessive fatigue; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, high blood pressure (HBP),hypothyroidism, migraine, lymphedema, chronic pain, artificial joints- total knee replacement (TKR) both knees, both hands/thumbs; spinal fusion/plates/screws/bone at C5 &C7, hysterectomy and known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications for HBP, migraines, anxiety and pain within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took nitrofurantoin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 06:30, the patient experienced slight fever (100.3). Her regular temperature was usually around 96.5. She also experienced wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea. On the same day, the patient underwent body temperature test and the result was 100.3 (unit unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with   ipratropium bromide (ATROVENT NEBULIZER), salbutamol (VENTOLIN), paracetamol (TYLENOL) and ondansetron (ZOFRAN) . Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's slight fever (100.3), wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
emotional feelings; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 32 year-old male patient received bnt162b2 (COMIRNATY), administered in arm right, administration date 26Oct2021 (Batch/Lot number: unknown) at the age of 32 years as dose 1 single for covid-19 immunisation. Relevant medical history included: "Lung cancer", start date: 2004 (unspecified if ongoing). There were no concomitant medications. The following information was reported: EMOTIONAL DISORDER (non-serious) with onset 26Oct2021, outcome "not recovered", described as "emotional feelings".  Additional information: He got his first dose of COVID19 vaccine about a week ago. He has been searching online about side effects and thinks he is experiencing something new. It was definitely not there before the vaccine. When asked to explain the side effects that he is experiencing caller stated he is experiencing emotional feelings. It started as soon as the shot entered the body. He got the vaccine on Tuesday, 26Oct2021. The emotional feeling is still happening. Caller confirmed that his emotional feelings are not thoughts of self-harm. No prior vaccinations (within 4 weeks) and no AE(s) following prior vaccinations. No lab test and no additional vaccines administered on Same Date of the Pfizer Suspect.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2 days p/shot pt had limp spells w/staring & followed by crying; no LOC; had grand mal sz;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old male patient received BNT162b2 (BNT162B2), on 09Jan2021 at 14:15 as dose 1, single (Batch/Lot number: unknown), in right arm, on 30Jan2021 at 13:30 as dose 2, single (Batch/Lot number: unknown), in right arm and on 01Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 77 years, in right arm for covid-19 immunisation. The patient had no relevant medical history and Known allergies: NKA. Concomitant medication(s) included: ROSUVASTATIN, start date: Jan2015, stop date: 18Jul2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient had a positive COVID-19 test on 08/25/2021but did not have pulmonary symptoms related to this test. Incidental finding. She was admitted to the hospital with anemia and new large hepatic masses that was diagnosed as hepatocellular carcinoma. Patient ended up with a palliative/hospice approach due to her significant co-morbidities, but they were not related to pulmonary function or COVID-19. The test was positive when she was admitted to the hospital.
Felt fine after the shot. Woke up feeling fine the next day and then about 2 pm my tongue felt like it was on fire and so did the fingers on my right arm. Now my whole body hurts and I feel like I?m going to throw up.
Received shot on 2/18, notice large raised, red, hot rash on 2/21 that had spread around large area of upper arm near injection site. Rash was sore closer to injection site. At the time of this report (2/22) rash still is still apparent.
Resident displayed tachycardia, diaphoresis, severe weakness - transfer to hospital from skilled facility
Pt's arm swelled till it was very tight. Local itching and heat was present. Site is red with tiny fluid filled blisters from rubbing and scratching. Cold compresses applied, Benadryl taken orally to control itching.
lt deltoid inj hot, swollen;this followed by myalgia of musclew/arm & upper back;
Patient received a 12 years of age and older vaccine instead of the under 12 years of age.
within a few minutes felt burning at the injection site down her arm, and radiating up her neck. also felt tingling in her fingers and may have felt something similar down her right leg. as of 9/14/23 still had symptoms
Right arm erythema, warmth and pain starting one day after receiving Pneumococcal and influenza shots in same arm.
Information has been received from a physician concerning a 2 month old female who on approximately 15-JAN-2008 in the middle of January, was vaccinated PO with her first 2.0 ml dose of ROTATEQ (no lot# provided). On that same day approximately, the patient experienced consistent vomiting and diarrhea for 4 days. The patient sought unspecified medical attention. On approximately 19-JAN-2008 the patient recovered. There was no product quality complaint. Additional information has been requested.
Information has been received from a 41 year old female consumer reporting on herself with diabetes and a history of shingles who a couple of months ago was subcutaneously vaccinated with one dose of 0.65 mL ZOSTAVAX (Merck) (lot# and expiration not reported). The consumer reported that she got ZOSTAVAX (Merck) a couple of months ago and four weeks later got a painful case of shingles. It was unspecified if the patient sought medical attention. The patient recovered on an unspecified date. Additional information has been requested.
TOOK TWO DOSES OF VIVOTIF ON THE SAME DAY; This spontaneous case was received from a nurse on 13-Jun-2019. It describes an 18-year-old male consumer who "took two doses of Vivotif on the same day". The consumer was receiving Vivotif for an unknown indication.  Case report: The consumer took two doses of Vivotif on the same day.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses of Vivotif on the same day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses of Vivotif on the same day" was considered as not applicable.
Vaccinated with Pediarix, Prevnar and Hib on 3/22/07-same evening woke up from sleep screaming, afterwards calmed down but later became hyporesponsive for 5-10 mins. No convulsions
intense hives all over my body. currently on prednisone, halobetasol propionate cream and benadryl.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 09-APR-2008, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On an unspecified date during 2016, the patient was treated at a hospital by a physician for a persistent and severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
-migrating lymphadenopathy -it started on the left underarm , and in the past two months have been moving in the different areas of the body; right pectoris, groin area ,left ear, right ear . Symptoms don't improve or get worst since the start. No fever, no weight loos and no other symptoms.
Pain in the arm; redness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) and ERYTHEMA (redness in the arm) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 091D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, LAMOTRIGINE and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm) and ERYTHEMA (redness in the arm). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) and ERYTHEMA (redness in the arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Treatment medications were provided.   This case was linked to MOD-2021-272996 (Patient Link).